Somatix regulatory update

The Alameda, Calif., company today was to announce notices of allowance in Europe and Australia for a patent covering tumor cells genetically modified by an introduced gene that stimulates an immune response. SOMA has an exclusive license to the patent from the M. D. Anderson Cancer Center and the Johns Hopkins University. ...